EchoGo® Heart Failure vs HeartFlow Analysis
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A focuses on detecting Heart Failure with Preserved Ejection Fraction (HFpEF) by analyzing echocardiograms, providing rapid insights for clinical decisions. In contrast, Tool B specializes in diagnosing and managing Coronary Artery Disease (CAD) through AI-powered 3D modeling and analysis of standard CT scans. While both are AI tools for cardiac imaging, their distinct disease targets and input modalities make them complementary rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is an AI platform designed to detect Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing routine echocardiograms. HeartFlow Analysis provides a non-invasive solution for diagnosing and managing Coronary Artery Disease (CAD) by creating personalized 3D models from standard CT scans.
EchoGou00ae Heart Failure analyzes routine echocardiogram video clips to provide insights. HeartFlow Analysis utilizes data from standard CT scans to generate its personalized 3D models and analyses.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis. HeartFlow Analysis uses Category I CPT codes 75580 for FFRct Analysis and 75577 for AI-Enabled Quantitative Plaque Analysis (effective 2026), both covered by Medicare and most commercial payers.
EchoGou00ae Heart Failure delivers AI-powered HFpEF detection and automated structured reports within 20 minutes. HeartFlow Analysis provides AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), and Roadmapu2122 Analysis for CCTA reading.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection. HeartFlow Analysis has demonstrated high diagnostic accuracy, with its Plaque Analysis showing accuracy as high as 95% compared to intravascular ultrasound (IVUS) and FFRct analysis showing 84% sensitivity and 86% specificity per vessel against invasive FFR.
EchoGou00ae Heart Failure offers seamless integration with existing workflows and IT stacks, using a DICOM workflow for report delivery to PACS. HeartFlow Analysis is cloud-based and provides a non-invasive diagnostic assessment from standard CT scans, with results delivered to physicians via a secure web interface.
EchoGou00ae Heart Failure provides insights and reports within 20 minutes of analyzing routine echo video clips. HeartFlow Analysis delivers information to a secure web interface after a few hours of calculation, allowing for quick patient results.